Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. Summary
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/14/2021 10/15/2021 10/18/2021 10/19/2021 10/20/2021 Date
206.78(c) 207.84(c) 203.13(c) 206.78(c) 209.66 Last
3 015 116 3 684 585 2 812 533 2 480 608 2 308 225 Volume
+1.56% +0.51% -2.27% +1.80% +1.39% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 26 010 M - -
Net income 2021 5 801 M - -
Net Debt 2021 22 276 M - -
P/E ratio 2021 20,5x
Yield 2021 3,40%
Sales 2022 27 148 M - -
Net income 2022 7 691 M - -
Net Debt 2022 19 341 M - -
P/E ratio 2022 14,6x
Yield 2022 3,62%
Capitalization 117 B 117 B -
EV / Sales 2021 5,37x
EV / Sales 2022 5,04x
Nbr of Employees 24 300
Free-Float 99,8%
More Financials
Company
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN... 
Sector
Pharmaceuticals
Calendar
11/02Earnings Release
More about the company
Ratings of Amgen Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about AMGEN INC.
01:52pAMGEN : A Special Edition of Innovation2, brought to you by David and Jim Reese (Brothers2..
PU
08:56aCARLYLE : Venture Funds Invest Up to $430 Million in Saama Technologies
MT
10/19AMGEN : Completes Teneobio Acquisition
MT
10/19AMGEN : Successfully Completes Acquisition Of Teneobio, Inc.
PR
10/19AMGEN : Named One of the ‘World's Best Workplaces'
PU
10/19Amgen Inc. completed the acquisition of TeneoBio, Inc. from Lightspeed Ventures, LLC an..
CI
10/18AMGEN : Third-Longest Tenured Employee Leaves a Legacy After 35 Years of Service
PU
10/18AMGEN : “Green” Chemistry Makes Pharmaceutical Manufacturing Better for the Pl..
PU
10/18AMGEN : Software firm Informatica eyes $9 bln valuation in stock market return
RE
10/15Analysis-Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/15Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/13LUYE PHARMA : Chinese Regulators Accept Luye Pharma's Marketing Authorization for Osteopor..
MT
10/12AMGEN : Morgan Stanley Adjusts Amgen PT $235 from $251, Keeps Equalweight Rating
MT
10/11AMGEN : Working Together to Improve Public Health Outcomes
PU
10/08ADRs Close Higher; Oil Majors Trade Actively
DJ
More news
News in other languages on AMGEN INC.
10/19Amgen conclut l'acquisition de Teneobio
10/19WALL STREET : entame bien novembre malgré taux et baril à 83$
10/18ASTRAZENECA : rejet d'une 'mini-offre' lancée par TRC Capital
10/13Les autorités réglementaires chinoises acceptent l'autorisation de commercialisation de..
10/08AstraZeneca obtient de la FDA la désignation de médicament orphelin pour son médicament..
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | AMGN | US0311621009 | MarketScreener
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 206,78 $
Average target price 243,14 $
Spread / Average Target 17,6%
EPS Revisions
Managers and Directors
Robert A. Bradway Chairman, President & Chief Executive Officer
Peter H. Griffith Chief Financial Officer & Executive Vice President
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Mike Zahigian Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
AMGEN INC.-10.06%117 421
JOHNSON & JOHNSON4.12%431 385
ROCHE HOLDING AG15.84%337 562
NOVO NORDISK A/S57.04%239 813
PFIZER, INC.12.25%235 986
ELI LILLY AND COMPANY43.51%219 674